PON2 silencing in oral cancer cell lines led to a significant reduction of both cell proliferation and viability, to the induction of apoptosis pathway, as well as to a marked enhancement of sensitivity to CDDP treatment. This evidence concerns the gene PON2 and lip and oral cavity carcinoma.